The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …
AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …
A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …
US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …

The Medical Research Council’s chief executive Sir Leszek Borysiewicz is stepping down later this year to become vice chancellor of …

Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …

A number of pharmaceutical companies have sprung into action to help the relief effort in Haiti. The island has been …
The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …
NICE is moving to update its clinical guidance on the management of chronic heart failure in adults. Draft recommendations are …

Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …

Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
The head of Monitor, the body charged with regulating the leading ‘foundation trust’ hospitals, has aired his views on the …

Cephalon’s executive vice president of worldwide pharmaceutical operations Robert Roche is leaving the company at the beginning of February to …

A microdose study is performed at an early stage of development in order to obtain preliminary pharmacokinetic or distribution data …
The MSI Consultancy has launched a new division to help the pharma industry maximise the impact of its brands. The …

In this week’s roundup: Roche answers cancer testing questions, Novartis uses SMS in fight against malaria, UCB goes to Facebook …
Few NHS trusts are following NICE’s 2006 guidelines on dementia, according central government auditor the National Audit Office. A NAO …

Bristol-Myers Squibb’s external affairs director Richard Marsh has moved to PR agency Fleishman-Hillard, where he takes up the role of …

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …